HRES 694
Expressing the sense of the House of Representatives that the Centers for Medicare & Medicaid Services should halt the pilot program and should not jeopardize seniors' access to critical health care by utilizing artificial intelligence to determine Medicare coverage.
TL;DR
Rep. Greg Landsman (D-OH) introduced a non-binding House resolution urging CMS to halt its WISeR pilot program, which uses AI to help make Medicare prior authorization decisions. It expresses the sense of the House but does not carry the force of law.
How This Might Impact Your Business
Healthcare AI vendors selling prior authorization or coverage determination tools to CMS face reputational and political headwinds, even though the resolution itself is non-binding.
Medicare Advantage plans and contractors participating in the WISeR pilot could see the program paused or scaled back if CMS responds to congressional pressure.
Health systems and providers that have adapted workflows around AI-driven prior authorization may face uncertainty about whether those processes continue.
No compliance requirements, penalties, or deadlines are created; this is a messaging resolution, not a statute or regulation.
Signals growing bipartisan skepticism of AI in coverage decisions, which could foreshadow binding legislation or CMS rulemaking restricting algorithmic denials.
Companies marketing AI tools for insurance claims adjudication should expect increased scrutiny from Congress, media, and advocacy groups focused on senior care.
What Should You Do
Healthcare AI vendors should prepare talking points and evidence (accuracy rates, human-in-the-loop safeguards) demonstrating their tools do not automate denials of care.
Medicare Advantage plans and CMS contractors should assess exposure to the WISeR pilot and model scenarios where the program is paused or modified.
Government affairs teams should track companion legislation or CMS guidance that could convert this sentiment into binding rules.
Communications and compliance leaders at any company using AI in coverage or benefits decisions should review public-facing disclosures about human oversight.
Monitor the House Ways and Means and Energy and Commerce Committees for related hearings or markups.
Who It Affects
Sponsors
Status Timeline
committee
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
September 10, 2025